These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 209533)

  • 1. Pharmacokinetic and therapeutic studies of pivmecillinam in patients with normal and impaired renal function.
    Ekberg M; Denneberg T; Larsson S; Juhlin I
    Scand J Infect Dis; 1978; 10(2):127-33. PubMed ID: 209533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivmecillinam treatment of chronic urinary tract infection.
    Kalager T; Bøe E; Digranes A; Høisaether P; Solberg CO
    Infection; 1978; 6(1):21-2. PubMed ID: 204581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with pivmecillinam in patients with recurrent bacteriuria.
    Bresky B; Lincoln K
    J Int Med Res; 1982; 10(3):179-82. PubMed ID: 6284565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection.
    Brumfitt W; Franklin I; Hamilton-Miller J; Anderson F
    Scand J Infect Dis; 1979; 11(4):275-9. PubMed ID: 231299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of pivmecillinam in urinary tract infection caused by Staphylococcus saprophyticus].
    Hovelius B; Mårdh PA
    Lakartidningen; 1982 Sep; 79(35):2965-7. PubMed ID: 6292596
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of pivmecillinam in intractable urinary-tract infections with complications. A comparative study with amoxicillin by a randomized double-blind technique.
    Ishigami J; Tanikaze S; Miyazaki S; Ono S; Kuroda M; Hirooka K; Mita T; Sugimoto M; Kuroda K; Nakatsuka E; Suemitsu H; Tomioka S; Takahashi Y; Hara S; Terasoma K; Tanaka K; Ueharaguchi H; Hikosaka K; Yasumuro T; Kaneda K; Akita Y; Okano H; Kobayashi M; Kataoka N
    Jpn J Antibiot; 1977 Nov; 30(11):928-39. PubMed ID: 201786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. A double-blind comparison with pivmecillinam.
    Igesund A; Vorland L
    Scand J Infect Dis; 1982; 14(2):159-60. PubMed ID: 6285450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice.
    Place C
    Pharmatherapeutica; 1981; 3(1):55-60. PubMed ID: 6275417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pivmecillinam in the treatment of urinary tract infections. Clinical effects and side effects].
    Spreer A; Weissbach L; Krasemann C
    Med Welt; 1980 Jan; 31(4):152-5. PubMed ID: 6245325
    [No Abstract]   [Full Text] [Related]  

  • 10. Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination.
    Andersen BT; Joergensen M; Lorenzen J
    Infection; 1980; 8(1):27-31. PubMed ID: 6246005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivmecillinam in complicated urinary infections failing to respond to conventional therapy.
    Brumfitt W; Hamilton-Miller JM
    Infection; 1982; 10(3):149-52. PubMed ID: 6286501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. Double-blind comparison with pivmecillinam alone in hospitalized patients.
    Scand J Infect Dis; 1983; 15(2):195-9. PubMed ID: 6308755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pivmecillinam (Selexid)].
    Jensen G
    Ugeskr Laeger; 1978 Apr; 140(16):925-6. PubMed ID: 206996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of pivmecillinam in urinary tract infections. 3].
    Iwao N; Kajikawa J; Nishimoto N; Miyoshi S; Mizutani S
    Jpn J Antibiot; 1982 Aug; 35(8):2005-14. PubMed ID: 6296477
    [No Abstract]   [Full Text] [Related]  

  • 15. Pivmecillinam in treatment of Staphylococcus saprophyticus urinary tract infections.
    Granlund M; Landgren E; Henning C
    Scand J Infect Dis; 1983; 15(1):65-9. PubMed ID: 6302831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of 3-day and 7-day chemotherapy with pivmecillinam in urinary tract infections in general practice.
    Marsh BT; Menday AP
    J Int Med Res; 1980; 8(2):105-11. PubMed ID: 6245976
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study on clinical effectiveness of mecillinam and pivmecillinam versus ampicillin in acute urinary infections (author's transl)].
    Seppelt U; Bertermann H; Sonntag HG
    Arzneimittelforschung; 1982; 32(5):569-71. PubMed ID: 6285939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride.
    Anderson JD; Adams MA
    Chemotherapy; 1979; 25(1):1-4. PubMed ID: 217572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the new type pivmecillinam tablet (contains 100 MG) on the treatment for female acute simple urinary tract infections (author's transl)].
    Furusawa T; Itakura Y; Miyashita H; Nakao M
    Jpn J Antibiot; 1981 Aug; 34(8):1191-5. PubMed ID: 6275143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivmecillinam in the treatment of recurrent urinary infection in girls.
    Deasy PF; Lynch K
    Ir Med J; 1980 Oct; 73(10):388-9. PubMed ID: 6253414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.